<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The association between EBV and two human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and NPC) is presented </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> prospective study conducted by the International Agency for Research on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> is progressing well, and up to date 10 pre-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> sera have been available and tested </plain></SENT>
<SENT sid="2" pm="."><plain>The results show that not only every serum has VCA antibodies 7 to 31 months prior to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> development, but that the VCA titres of such pre-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> sera appear higher than that of various age-sex matched controls </plain></SENT>
<SENT sid="3" pm="."><plain>These preliminary results would favour a <z:hpo ids='HP_0011010'>chronic</z:hpo> and heavy <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> as a risk factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The role of co-factors, such as <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>, is discussed together with proposals of anti-<z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> partial suppression scheme </plain></SENT>
<SENT sid="5" pm="."><plain>The association between HSV-2 and cervical <z:mp ids='MP_0002038'>carcinoma</z:mp> is weaker, and HSV-2 infection could become an epidemiological marker, rather than an etiological agent for the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> </plain></SENT>
</text></document>